MDxHealth SA

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Revenues $11.8m
$18.5m +56.64%
$22.2m +20.47%
$37.1m +66.62%
$70.2m +89.43%
$90.0m +28.29%
$107.9m +19.80%
$111.0m +2.87%
Cost of sales (exclusive of amortization of intangible assets) ($11.8m)
($10.4m) +11.39%
($11.7m) -12.09%
($17.8m) -52.76%
($26.3m) -47.26%
($34.9m) -32.91%
($38.2m) -9.55%
Gross profit $30k
$8.0m +26713.33%
$10.6m +31.33%
$19.2m +81.93%
$43.9m +128.57%
$55.1m +25.52%
$69.6m +26.28%
$70.7m +1.59%
Research and development expenses ($9.0m) ($4.5m) ($6.7m) ($7.6m) ($6.4m) ($10.6m) ($10.3m) $10.0m
Selling and marketing expenses ($17.8m) ($16.8m) ($17.7m) ($26.6m) ($36.9m) ($41.0m) ($42.6m) $71.6m
General and administrative expenses ($15.2m) ($14.0m) ($14.1m) ($23.5m) ($23.0m) ($22.8m) ($26.9m) $61.3m
Amortization of intangible assets ($1.6m) ($3.2m) ($4.5m) ($4.9m) ($5.2m)
Other operating income (expense), net ($1.2m) $118k $1.2m $559k ($461k) ($624k) $993k
Operating loss ($43.2m)
($27.1m) +37.17%
($26.8m) +1.04%
($37.9m) -41.20%
($27.3m) +27.90%
($24.7m) +9.53%
($14.4m) +41.72%
($18.1m) -25.52%
Loss before income tax ($43.7m) ($28.7m) ($29.0m) ($44.0m) ($43.1m) ($37.7m) ($35.4m)
Income tax benefit (expense) $575k $0 $0 $0 ($1k) ($382k) $1.9m
Basic (in Dollars per share) ($0.69) ($0.34) ($0.24) ($0.28) ($1.66) ($1.16) ($0.67)
Diluted (in Dollars per share) ($0.69) ($0.34) ($0.24) ($2.78) ($1.66) ($1.16) ($0.67)
Financial income $10k $4k $11k $241k $2.6m $2.4m $2.1m
Financial expenses ($516k) ($1.5m) ($2.2m) ($6.1m) ($18.3m) ($15.3m) ($23.0m)
Loss for the year attributable to owners of the parent ($43.1m) ($28.7m) ($29.0m) ($44.0m) ($43.1m) ($38.1m) ($33.5m)